Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the Safety of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children With Asthma of Varying Levels of Severity

NCT03600428 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03600428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03600428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the Safety of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children With Asthma of Varying Levels of Severity
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
October 15, 2018
Completion date
March 20, 2020
Enrollment
152 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma in children, influenza, vaccine adverse reaction, vaccine reaction, wheezing